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ABSTRACT
The antimicrobial susceptibility patterns are on constant change with the recent emergence of multidrug-
resistant strains of most bacteria. Results of recent studies in India showed that most isolates of Vibrio 
cholerae O1 were resistant to the commonly-used antibiotics. The study was conducted to determine the 
antibiotic susceptibility patterns of V. cholerae O1 isolated during 2008-2010 at the hospital of the Jawaharlal 
Nehru Institute of Post Graduate Medical Education and Research, Puducherry, India. In total, 154 strains 
of V. cholerae O1 from 2,658 stool specimens were reported during January 2008–December 2010—34 in 
2008, 2 in 2009, and 118 in 2010. The isolates of V. cholerae O1 were subjected to antimicrobial susceptibili-
ty testing using the Kirby-Bauer method. The antibiotic disks tested were tetracycline (30 μg), furazolidone 
(100 μg), ampicillin (10 μg), ceftriaxone (30 μg), and ciprofloxacin (5 μg). Escherichia coli ATCC 25922 
was used as the control organism. The minimum inhibitory concentrations (MICs) of ceftriaxone, cipro-
floxacin, and tetracycline were determined using the agar dilution method for all the strains. The E-test 
method was used for the strains which had either intermediate resistance or were resistant to the antibiotics 
by the agar dilution method. The results of the agar dilution corroborated the results of the E-test. The MIC 
of ceftriaxone in 151 strains was <2 μg/mL while it was 16 μg/mL in three strains; the latter three strains 
were resistant to ceftriaxone by the disc-diffusion test. The MIC of ciprofloxacin in 150 strains was <0.5 
μg/mL while the MIC of tetracycline was <1 μg/mL. In the remaining four strains, the MIC of tetracycline 
was >32 μg/mL, and the MIC of ciprofloxacin was >8 μg/mL. These four strains were resistant to both tet-
racycline and ciprofloxacin by the disc-diffusion test and were exclusive of the three ceftriaxone-resistant 
strains. The majority of the isolates were obtained from children aged 0-5 year(s)—70.3% (83 of 118) and 
41.2% (14 of 34) were reported in 2010 and 2008 respectively. Since treating severe cases of cholera with 
antibiotics is important, the continuing spread of resistance in V. cholerae to the most important agents of 
therapy is a matter of concern. Also, chemoprophylaxis with antimicrobial agents is likely to become even 
more difficult.
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INTRODUCTION
Vibrio cholerae O1, the causative organism of epi-
demic cholera, continues to be a major health 
problem in most parts of developing nations in the 
world. The outbreaks of cholera follow a seasonal 
pattern in regions of endemicity, reflecting the 
shifts in climatic conditions that lead to preferen-
tial selection of hosts by the causal organisms (1-3). 
The replacement of fluid and electrolytes plays a 
major role in treating cases of cholera. Antibiotics 
as well play a major role in reducing the shedding 
of the bacillus, thereby preventing the spread of the 
disease, in treating severe illness by reducing the 
volume of diarrhoea, and also reducing the dura-
tion of illness and hospitalization (4).
The antibiotics commonly used in the treatment 
of cholera include tetracycline and fluoroquinolo-
nes, such as ciprofloxacin, among others. The an-
timicrobial susceptibility patterns of V. cholerae O1 Mandal J et al. Vibrio cholerae and antibiotic resistance
Volume 30 | Number 1 | March 2012 13
strains from newly-infected patients are on con-
stant change following the recent emergence and 
spread of multidrug-resistant strains (1-6). Results 
of recent studies in India showed that most isolates 
of V. cholerae O1 were resistant to the commonly-
used antibiotics, such as ampicillin, furazolidone, 
ciprofloxacin, and tetracycline (4,6). Resistance of 
V. cholerae to ceftriaxone has been reported from 
Argentina (7) and recently from Delhi, India (8).  
There is no report regarding resistance to the third-
generation cephalosporins from our region, this 
being the first. Also, no consolidated data are avail-
able on the antimicrobial susceptibility patterns of 
the organism concerned. The present study was 
conducted to determine the antibiotic suscep-
tibility patterns of V. cholerae O1 isolated during 
2008-2010 at the hospital of the Jawaharlal Nehru 
Institute of Post Graduate Medical Education and 
Research (JIPMER), Puducherry, India.   
MATERIALS AND METHODS
The study was conducted at the Department of 
Microbiology, JIPMER, Puducherry, India. The study 
samples included strains of V. cholerae O1 obtained 
from 2,658 consecutive stool samples of patients 
with cholera-like disease during January 2008–De-
cember 2010.
The stool samples were inoculated onto MacConkey 
agar and thiosulphate-citrate-bile salts-sucrose agar 
(HIMEDIA, Mumbai). Enrichment was done with 
alkaline peptone water, from which subculture was 
performed after six hours of incubation at 37 °C 
onto MacConkey agar and thiosulphate-citrate-bile 
salts-sucrose agar. Suspected colonies were identi-
fied as V. cholerae by the standard biochemical tests 
(9-11), and the serogroup was confirmed by ag-
glutination with specific antiserum (BD DifcoTM, 
Becton Dickinson, Sparks, Maryland, USA). Anti-
microbial susceptibility testing was done using the 
Kirby-Bauer method (12-14). The antibiotic disks 
tested were tetracycline (30 μg), furazolidone (100 
μg), ampicillin (10 μg), ceftriaxone (30 μg), and 
ciprofloxacin (5 μg). Escherichia coli ATCC 25922 
was used as the control organism. The minimum 
inhibitory concentrations (MICs) of ciprofloxacin, 
ceftriaxone, and tetracycline were determined by 
the agar dilution method (14,15) and the E-test 
(BioMe´rieux) method. The MICs of ceftriaxone, 
ciprofloxacin, and tetracycline were determined 
by the agar dilution method for all the strains. The 
E-test method was used for the strains which had 
either intermediate resistance or were resistant to 
the antibiotics by the agar dilution method. 
The double-disk synergy test was performed as des-
cribed earlier (16) on the three strains which had 
intermediate resistance to ceftriaxone.
RESULTS
Of the 2,658 stool samples obtained from patients, 
154 isolates of V. cholerae were reported during Jan-
uary 2008–December 2010, of which 34 were re-
ported in 2008 and 2 in 2009. These cases were usu-
ally documented in May to August of every year. 
Subsequently, 118 cases were reported in 2010 as 
there was an outbreak of cholera in Puducherry. 
The majority of the reported isolates were from 
children aged 0-5 year(s)—70.3% (83 of 118) and 
41.2% (14 of 34) were reported in 2010 and 2008 
respectively (Table 1). Analysis of the common se-
rotypes isolated during the outbreaks of 2008 and 
2010 revealed that Ogawa accounted for 97.1% (33 
of 34) and 97.5% (113 of 118) of the cases in 2008 
and 2010 respectively (Table 2). Oral rehydration 
therapy was administered to these patients as the 
primary treatment, followed by antibiotics, such as 
doxycycline or ciprofloxacin.  
There was a significant difference [p<0.0001, 95% 
confidence interval (CI) 0.9290-0.9975] in the re-
sistance pattern of the strains isolated in 2010 and 
2008 for ampicillin. There was also a significant 
difference (p<0.0001; 95% CI 0.024-0.1175) in the 
resistance pattern of the strains isolated in 2010 
and 2008 for furazolidone. The resistance patterns 
for ciprofloxacin and tetracycline did not have any 
significant difference but had a marginal increase 
(p=0.5; 95% CI 0.000-0.5217 and p=0.49; 95% CI 
0.043-0.348 respectively).
Three strains were resistant to ceftriaxone while 
four were resistant to tetracycline and ciprofloxacin 
simultaneously by the disc-diffusion method (Table 
3). As only two strains were isolated in 2009, these 
were not included in the table. Both these strains 
were sensitive to all the antibiotics tested.  
The MIC of ceftriaxone in the 151 strains was <2 
μg/mL while it was 16 μg/mL in three strains; the 
latter three strains were resistant to ceftriaxone by 
the disc-diffusion test. The MIC of ciprofloxacin in 
the 150 strains was <0.5 μg/mL while the MIC of 
tetracycline was <1 μg/mL. In the remaining four 
strains, the MIC of tetracycline was >32 μg/mL, 
and the MIC of ciprofloxacin was >8 μg/mL. These 
four strains were resistant to both tetracycline and 
ciprofloxacin by the disc-diffusion test and were 
exclusive of the three ceftriaxone-resistant strains. 
The double-disk synergy test was negative.
DISCUSSION
The emergence and the spread of resistance to an-
tibiotics among Gram-negative organisms have 
been increasing rapidly in recent years. The epide-Mandal J et al. Vibrio cholerae and antibiotic resistance
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Table 1. Distribution of cholera cases in different years
Age (years)
2010 2009 2008
No.                % No.             % No.            %
0-5 83               70.3 1                 50 14            41.2
6-15 11                9.3 1                 50  6             17.6
>15 24               20.4        0                   - 14            41.2
Total         118                  -        2                   -         34               -
Table 2. Distribution of serotypes of Vibrio cholerae isolated in different years
Serotype
2010 2009 2008
No.                % No.             % No.             %
Ogawa 115               97.5  2               100 33             97.1
Inaba 3                  2.5 0                50 1               2.9
miological importance of preventing these drug-
resistant strains from spreading in the community 
has become a global problem (6). V. cholerae is a 
potent pathogen which can be transmitted easily 
in the community by the faeco-oral route, in the 
existing sanitary systems, particularly in develop-
ing countries. In 2008, 88% of the population in 
India had access to an improved water source but 
only 31% had access to improved sanitation. In 
rural areas where 72% of the population of India 
lives, the shares are 84% for water and only 21% for 
sanitation. In urban areas, 96% had access to an im-
proved water source and 54% to improved sanita-
tion. Access has improved substantially since 1990 
when it was estimated to stand at 72% for water 
and 18% for sanitation. With all these combined 
and considering the potential of this organism in 
causing epidemics, the emergence of resistance to 
antibiotics in such a scenario can have serious ef-
fects.
After the 1980s, plasmid-encoded high-level resist-
ance to tetracycline, ampicillin, and sulphonamides 
was reported from different parts of the world. 
Subsequently, nalidixic acid became the drug of 
choice for the empirical treatment of gastroenteritis 
but this has soon met the same fate as of its prede-
cessors (17-20). The widespread prophylactic use 
of certain antibiotics, such as tetracycline and co-
trimoxazole, and their ease of availability over-the-
counter have added to the selective pressure for the 
emergence of multiple antibiotic-resistant V. chole-
rae (MARV) (17, 21-23). 
Table 3.  Comparison of antibiotic resistance patterns of isolates by the disc-diffusion method in 
different years
Year
Strains 
isolated
Ampicillin  Ciprofloxacin  Ceftriaxone  Furazolidone  Tetracycline 
No.        % No.      % No.       % No.       % No.      %
2010 118 97        82.2 5         4.2 3         2.5 112       95 22      18.6
2008 34 2          5.9 0           - 0           -  7         21 4         12
Total 154 99        64.3 5         3.2 3          2  119      77.3 26      16.9
Following the emergence of V. cholerae O139 in 
June 1992, there has been a marked variability in 
the susceptibility patterns of O1 strains, with the 
reporting of a higher proportion of MARV strains 
(22,23). Continued surveillance revealed a different 
resistance pattern wherein the strains were more 
frequently resistant to tetracycline and ampicil-
lin. The emerging strains possessed extra genetic 
elements which indicate that significant genomic 
changes have occurred (22). Recent strains have 
shown an increasing trend of resistance to fluo-
roquinolones (23,24). These findings suggest that 
there has been substantial mobility of genetic ele-
ments in V. cholerae, which could have contributed 
to the emerging drug resistance.
In this study, children aged less than five years were 
more commonly involved (Table 1). The majority 
of the isolates were obtained from children aged 
0-5 year(s)—70.3% (83 of 118) and 41.2% (14 of 
34) were reported in 2010 and 2008 respectively. 
This finding should be taken into consideration as 
the use of antibiotics in these age-groups is already 
limi-ted by contra-indications. 
The predominance of the Ogawa serotype (n=33; 
97.1% and n=115; 97.5% respectively) in 2008 and 
2010 (Table 2) suggests that it is currently the pre-
dominant circulating serotype in this part of the 
country. The seasonal association of cases was ob-
served. Most cases occurred in May, and the cluster-
ing of cases was observed till August. In 2010, there 
were two outbreaks—one in May and the other Mandal J et al. Vibrio cholerae and antibiotic resistance
Volume 30 | Number 1 | March 2012 15
one just after November. This clustering of cases 
can be referred to the rainfall during these months. 
The strains belonging to the initial outbreak were 
similar in their antibiotic susceptibility patterns to 
the second outbreak, with a pattern of ampicillin
>furazolidone>tetracycline>ciprofloxacin; all the 
strains were sensitive to ceftriaxone. Their similar 
antibiotic susceptibility pattern probably points 
to their related clonality. Molecular studies are be-
ing planned to understand the relatedness of these 
strains. Results of analysis of the available antimi-
crobial susceptibility patterns of V. cholerae in 2008 
and 2010 (Table 3) revealed that the organism has 
rapidly gained resistance to antibiotics to which it 
was previously sensitive. The antibiotic susceptibili-
ty pattern observed in this study is indicative of an 
increasing trend of resistance in the strains isolat-
ed. Similar findings have been reported elsewhere 
(4,18-20,23). 
The World Health Organization recommends the 
use of either doxycycline or ciprofloxacin as the 
treatment of choice (17). Since the treatment of se-
vere cases of diarrhoea is important, the emergence 
of resistance of V. cholerae to the most important 
agents of therapy for cholera is a matter of concern. 
Further molecular studies on these strains are being 
planned.
The negative results of the double-disk synergy test 
indicate that strains with intermediate resistance 
to ceftriaxone are not Class A extended-spectrum 
ß-lactamase (ESBL) producers but may be Class C 
ESBL producers or may possess some chromosomal 
mutation. Due to the lack of a genetic analysis of 
these strains, the exact nature of the underlying 
mechanisms mediating the reduced susceptibility 
of the strains to ceftriaxone is not clear. The causes 
of resistance to third-generation cephalosporins are 
(a) ESBL of any of the classes, (b) efflux pumps, and 
(c) chromosomal mutation. Reduced susceptibility 
to cephalosporins is chromosomally mediated, and 
the mechanisms resemble those for chromosoma-
lly-mediated penicillin resistance. An earlier study 
on an unrelated Gram-negative pathogen Neisse-
ria gonorrhoeae demonstrated that the presence of 
mosaic penA allele, mtrR, penB, and an unknown 
mutation was the important determinants for 
conferring intermediate resistance to expanded-
spectrum cephalosporins, such as ceftriaxone and 
cefixime (25). A detailed genetic study of the drug-
resistant strains is warranted in this regard.
Conclusions
Antimicrobial resistance has attained the impor-
tance of a global public-health problem. The in-
crease in the magnitude of bacterial species resistant 
to multiple antimicrobial agents relies on vari-
ous factors apart from the environmental stresses 
which the organism is facing over the years. The 
availability of over-the-counter drugs and wide-
spread institution of irrational chemoprophylaxis 
before the patient reaches a tertiary-care hospital 
in developing countries play an important role in 
the emergence of the expanding resistance pat-
terns to the organism (23,26). Oral tetracycline and 
fluoroquinolones, such as ciprofloxacin, have been 
and are being used extensively and misused for a 
number of infective conditions other than chole-
ra in our region. This indiscriminate use of such 
antimicrobials will soon result in their becoming 
ineffective against this organism. The current sce-
nario regarding drug resistance in V. cholerae is a 
matter of concern. Due to the rapid emergence of 
resistance to the empirically-given antibiotics for 
the treatment of cholera, therapeutic options are 
limited. This problem becomes more pronounced 
when the issue of treating cholera in special groups, 
such as children, women in the antenatal period, 
and lactating mothers arises. Thus, the antimi-
crobial profile of organisms, such as V. cholerae, 
should be under constant surveillance to prevent 
any dangerous epidemic arising from such drug-
resistant strains.
REFERENCES
1.  Sack RB, Rahman M, Yunus M, Khan EH. Antimicro-
bial resistance in organisms causing diarrheal disease. 
Clin Infect Dis 1997;24(Suppl 1):102-5.
2.  Sack DA, Sack RB, Nair GB, Siddique AK. Cholera. 
Lancet 2004;363:223-33.
3.  Mhalu FS, Mmari PW, Ijumba J. Rapid emergence of 
El Tor Vibrio cholerae resistant to antimicrobial agents 
during first six months of fourth cholera epidemic in 
Tanzania. Lancet 1979;1:345-7.
4.  Roychowdhury A, Pan A, Dutta D, Mukhopadhyay 
AK, Ramamurthy T, Nandy RK et al. Emergence of tet-
racycline-resistant Vibrio cholerae O1 serotype Inaba, 
in Kolkata, India. Jpn J Infect Dis 2008;61:128-9.
5.  Mandomando I, Espasa M, Vallès X, Sacarlal J, Si-
gaúque B, Ruiz J et al. Antimicrobial resistance of Vib-
rio cholerae O1 serotype Ogawa isolated in Manhiça, a 
district hospital, southern Mozambique. J Antimicrob 
Chemother 2007;60:662-4.
6.  Taneja  N,  Samanta  P,  Mishra  A,  Sharma  M.  Emer-
gence of tetracycline resistance in Vibrio cholerae O1 
biotype El Tor serotype Ogawa from north India. In-
dian J Pathol Microbiol 2010;53:865-6.
7.  Petroni A, Corso A, Melano R, Cacace ML, Bru AM, 
Rossi A, Galas M. Plasmidic extended-spectrum ß-
lactamases in Vibrio cholerae O1 El Tor isolates in Argen-
tina. Antimicrob Agents Chemother 2002;46:1462-8.Mandal J et al. Vibrio cholerae and antibiotic resistance
JHPN 16
8.  Sharma NC, Mandal PK, Dhillon R, Jain M. Changing 
profile of Vibrio cholerae O1, O139 in Delhi & its pe-
riphery (2003-2005). Indian J Med Res 2007;125:633-
40.
9.  Centers for Disease Control and Prevention. Labora-
tory methods for the diagnosis of epidemic dysentery 
and cholera. Atlanta, GA: Centers for Disease Con-
trol and Prevention, 1999:41-54. (WHO/CDS/CSR/
EDC/99.8).
10. Old DC. Vibrio, Aeromonas, Plesiomonas, Campylo-
bacter, Arcobacter, Helicobacter, Wolinella. In: Collee JG, 
Fraser BP, Marmion AG, Simmons A, editors. Mackie 
& McCartney Practical medical microbiology. 14th 
ed. Edinburgh: Churchill Livingstone, 1999:425-48.
11. Bradford KA, Cheryl BA, Joy WG. Isolation and iden-
tification of Vibrio cholerae O1 from fecal specimens. 
In: Wachsmuth IK, Blake PA, Olsvik O, editors. Vibrio 
cholerae and cholera: molecular to global perspectives. 
Washington, DC: American Society for Microbiology 
Press, 1994:3-25.
12. Bauer AW, Kirby WMM, Sherris JC, Turck M. Anti-
biotic susceptibility testing by a standardised single 
disk method. Am J Clin Pathol 1966,45:493-6.
13. Centers for Disease Control and Prevention. Manual 
for the laboratory detection of antimicrobial resist-
ance among acquired bacterial pathogens of public 
health concern in the developing world (draft). At-
lanta, GA: Centers for Disease Control and Preven-
tion, 2001:55-64. (CDC/WHO/USAID).
14. Clinical and Laboratory Standards Institute.  Meth-
ods for antimicrobial dilution and disk susceptibility 
testing of infrequently isolated or fastidious bacteria; 
approved guideline. 2nd ed. Wayne, PA: Clinical and 
Laboratory Standards Institute, 2010. 96 p. (M45A2).
15. Jorgensen JH, Turnidge JD. Susceptibility test meth-
ods: dilution and disk diffusion methods. In: Murray 
PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, 
editors. Manual of clinical microbiology. 9th ed. 
Washington, DC: American Society for Microbiology 
Press, 2003:1108-27.
16. Jarlier V, Nicolas M, Fournier G, Philippon A. Ex-
tended broad-spectrum beta-lactamases conferring 
transferable resistance to newer beta-lactam agents in 
Enterobacteriaceae: hospital prevalence and suscepti-
bility patterns. Rev Infect Dis 1988;10:867-78.
17. Sack DA, Lyke C, McLaughlin C, Suwanvanichkij V. 
Antimicrobial resistance in shigellosis, cholera and 
campylobacteriosis. Geneva: World Health Organiza-
tion, 2001:8-21. (WHO/CDS/CSR/DRS/2001.8).
18. Mukhopadhyay AK, Garg S, Nair GB, Kar S, Ghosh 
RK, Pajni S et al. Biotype traits and antibiotic suscep-
tibility of Vibrio cholerae serogroup O1 before, during, 
and after the emergence of the O139 serogroup. Epi-
demiol Infect 1995;115:427-34.
19. Mukhopadhyay AK, Garg S, Mitra R, Basu A, Ra-
jendran K, Dutta D et al. Temporal shifts in traits of 
Vibrio cholerae strains isolated from hospitalized pa-
tients in Calcutta: a 3-year (1993 to 1995) analysis. J 
Clin Microbiol 1996,34:2537-43.
20. Mukhopadhyay AK, Basu I, Bhattacharya SK, Bhatta-
charya MK, Nair GB. Emergence of fluoroquinolone 
resistance in strains of Vibrio cholerae isolated from 
hospitalized patients with acute diarrhea in Calcutta, 
India. Antimicrob Agents Chemother 1998;42:206-7.
21. Okeke IN, Lamikanra A, Edelman R. Socioeconomic 
and behavioral factors leading to acquired bacte-
rial resistance to antibiotics in developing countries. 
Emerg Infect Dis 1999;5:18-27.
22. Jesudason MV, John TJ. Transferable trimethoprim 
resistance of Vibrio cholerae O1 encountered in south-
ern India. Trans Roy Soc Trop Med Hyg 1990;84:136-7.
23.  Jesudason MV, Saaya R. Resistance of Vibrio cholerae  O1 
to nalidixic acid. Indian J Med Res 1997;105:153-4.
24. Baranwal S, Dey K, Ramamurthy T, Nair GB, Kundu 
M. Role of active efflux in association with target 
gene mutations in fluoroquinolone resistance in 
clinical isolates of Vibrio cholerae. Antimicrob Agents 
Chemother 2002;46:2676-8.
25. Zhao S, Duncan M, Tomberg J, Davies C, Unemo M, 
Nicholas RA. Genetics of chromosomally mediated 
intermediate resistance to ceftriaxone and cefixime 
in Neisseria gonorrhoeae. Antimicrob Agents Chemother 
2009;53:3744-51.
26. O’Brien TF: The global epidemic nature of antimicro-
bial resistance and the need to monitor and manage 
it locally. Clin Infect Dis 1997;24(Suppl 1):S2-8.